| Income Statement |
| Operating Expenses | 102.02M |
|
| Research and Development Expense | 51.81M |
| Selling, General and Administrative Expense | 50.20M |
| Operating Income | -102.02M |
| Interest Expense | 2.30M |
| Net Income | -105.51M |
| Net Income Common Stock | -105.51M |
| Net Income Common Stock (USD) | -105.51M |
| Consolidated Income | -105.51M |
| Earnings per Basic Share | -0.83 |
| Earnings per Basic Share (USD) | -0.83 |
| Earnings per Diluted Share | -0.83 |
| Earning Before Interest & Taxes (EBIT) | -103.21M |
| Earning Before Interest & Taxes (USD) | -103.21M |
| Weighted Average Shares | 127.28M |
| Weighted Average Shares Diluted | 127.28M |
| Balance Sheet |
| Cash and Equivalents | 434.35M |
| Cash and Equivalents (USD) | 434.35M |
| Investments | 49.40M |
| Investments Current | 49.40M |
| Current Assets | 515.28M |
| Property, Plant & Equipment Net | 11.57M |
| Total Assets | 535.25M |
| Debt Current | 6.08M |
| Total Debt | 205.67M |
| Current Liabilities | 59.64M |
| Debt Non-Current | 199.60M |
| Total Liabilities | 259.24M |
| Accumulated Retained Earnings (Deficit) | -1.41B |
| Accumulated Other Comprehensive Income | 690.00K |
| Shareholders Equity | 276.01M |
| Shareholders Equity (USD) | 276.01M |
| Assets Non-Current | 19.97M |
| Total Debt (USD) | 205.67M |
| Liabilities Non-Current | 199.60M |
| Trade and Non-Trade Payables | 9.22M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 1.88M |
| Net Cash Flow from Financing | 193.79M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 106.35M |
| Capital Expenditure | -68.00K |
| Issuance (Purchase) of Equity Shares | 101.47M |
| Issuance (Repayment) of Debt Securities | 92.31M |
| Net Cash Flow from Investing | -5.33M |
| Net Cash Flow - Investment Acquisitions and Disposals | -5.27M |
| Net Cash Flow from Operations | -82.10M |
| Effect of Exchange Rate Changes on Cash | 666.00K |
| Share Based Compensation | 18.25M |